Pharmaceutical

Mankind Pharma and Innovent partner for Sintilimab commercialisation in India

Mankind Pharma has entered into a partnership with Innovent Biologics for licensing and commercialising Sintilimab for cancer in India.

Dec 27, 2024 - 06:00
Mankind Pharma and Innovent partner for Sintilimab commercialisation in India
Mankind Pharma has entered into a partnership with Innovent Biologics for licensing and commercialising Sintilimab for cancer in India.
Read the original article

Tags:

Previous Article

Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst

Next Article

Eisbach Bio positions HRD-targeting therapy to supplant PARP inhibitors

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Weight-loss startup Calibrate cuts 18% of workforce as obesity drugs spark growing competition

STAT+: Weight-loss startup Calibrate cuts 18% of workfo...

Apr 15, 2023

Opinion: A new Louisiana capital-punishment bill would fundamentally alter physician licensing

Opinion: A new Louisiana capital-punishment bill would ...

Feb 27, 2024

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Fosun Pharma and IFC to build new drug manufacturing pl...

Jun 7, 2023